- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05187442
The Experiences of Erotic and Sexual Risk of Transgender Men: Exploratory Research Design
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Taipei, Taiwan, 100
- School of Nursing of National Taiwan University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
- The personal network of the research team is used to search for eligible TMs via social media platforms, such as Facebook (FB), Instagram (IG), and group of Line app.
- The recruitment materials will be published on transgender communities, social media platforms, non-governmental organizations, and YouTube, etc., to recruit the participants.
- The participants who finished the online questionnaire will be encourage to invite and transfer their network who meet the inclusion criteria via Line app or email address to our research team.
Description
First stage:
Inclusion Criteria:
- People who used to or currently self-identified as transgender men, regardless of whether they have sex reassignment surgery.
- Be over 20 years old.
- Citizen and live in Taiwan.
Exclusion Criteria:
- Not self-identify as transgender men
- Younger than 20 years old
- Not citizen and not live in Taiwan.
Second stage
- People who used to or currently self-identified as transgender men, transgender woman or non-binary, regardless of whether they have gender-affirming surgery.
- Be over 20 years old.
- Citizen and live in Taiwan.
Exclusion Criteria:
- Not self-identify as transgender men, transgender woman or non-binary.
- Younger than 20 years old
- Not citizen and not live in Taiwan.
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Cross-Sectional
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Experience of Erotic and Sexual Risk of Transgender Men(Demographic Data, Transgender Affirmation Questionnaire)
Time Frame: At time of entry into study
|
After signing the online consent form, fill out the demographic information form and transgender affirmation questionnaire on Google Forms to calculate population proportions and averages.(First
stage)
|
At time of entry into study
|
|
Ages of Transgender Men
Time Frame: At time of entry into study
|
After signing the online consent form, fill out the ages on Google Forms to calculate population proportions and averages.(First
stage)
|
At time of entry into study
|
|
Experience of Erotic and Sexual Risk of Transgender Men (Short Sexual Well Being Scale)
Time Frame: At time of entry into study
|
After signing the online consent form, fill out the Short Sexual Well Being Scale on Google Forms to calculate population proportions and averages.(First stage) Short Sexual Well Being Scale:There are a total of five questions, using a Likert 7 lit table, with scores ranging from 5 (minimum) to 35 (maximum), with the higher the score, the better Sexual Well Being. 1. I disagree completely, 2. I disagree, 3. I disagree a little, 4. Neutral, 5. I somewhat agree, 6. I agree, 7. I completely agree |
At time of entry into study
|
|
Experience of Erotic and Sexual Risk of Transgender Men (STIs Prevention Questionnaire)
Time Frame: At time of entry into study
|
After signing the online consent form, fill out the STIs prevention questionnaire on Google Forms to calculate population proportions and averages.(First
stage)
|
At time of entry into study
|
|
Violence Experience of Transgender (Experiences of Abuse & Coping Strategies)
Time Frame: months3-6(In the second stage)
|
In the second stage, focus groups and in-depth interviews will be conducted, 2 hours of each group and interview. The interview outline was revised based on the questionnaire analysis results, and TMs who met the research requirements were selected from the questionnaire respondents to conduct physical focus groups or in-depth face-to-face or video semi-structured interviews on the theme of violence experience. We also recruited Trans woman and non-binary gender groups to conduct focus groups and in-depth interviews to compare the differences in their experiences of violence. The data were categorized into two main themes:Experiences of Abuse & Coping Strategies. |
months3-6(In the second stage)
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 20210HS3001
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Transgender Persons
-
Oregon Health and Science UniversityCompletedTransgender Persons | Health Services for Transgender PersonsUnited States
-
Tel-Aviv Sourasky Medical CenterEnrolling by invitationTransgender | Transgender Persons, M01.777.500Israel
-
Boston Children's HospitalRecruitingTransgender Persons | Gender Identity | Health Services for Transgender PersonsUnited States
-
University of WashingtonNational Institute of General Medical Sciences (NIGMS)Completed
-
University of WashingtonCompleted
-
The University of Texas Health Science Center at...Foundation for Advancing Veterans' Health ResearchTerminated
-
University of Wisconsin, MadisonCompleted
-
Virginia Commonwealth UniversityRecruiting
-
St. Louis UniversityTerminatedTransgender PersonsUnited States
Clinical Trials on questionnaire, interview
-
Northwestern UniversityRegeneron PharmaceuticalsCompletedPsoriasis | Atopic Dermatitis | IchthyosisUnited States
-
Centre Hospitalier Universitaire DijonCompletedExpanded Newborn Screening | Parental AcceptabilityFrance
-
Imperial College LondonCompleted
-
ANRS, Emerging Infectious DiseasesInstitut National de la Santé Et de la Recherche Médicale, FranceCompletedHIV SeropositivityFrance
-
University Hospital, BordeauxRégion Nouvelle AquitaineCompletedObesity | Covid19France
-
Centre Hospitalier Intercommunal CreteilCompletedPsychology, Social | Psychological AdaptationFrance
-
Pfizer's Upjohn has merged with Mylan to form Viatris...Mayo Clinic; University of Chicago; Vanderbilt UniversityWithdrawnPulmonary Arterial Hypertension
-
Medical University of South CarolinaNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...CompletedSickle Cell Disease | Stroke IschemicUnited States
-
St. Jude Children's Research HospitalCompletedSickle Cell DiseaseUnited States
-
M.D. Anderson Cancer CenterNational Institute on Minority Health and Health Disparities (NIMHD)Completed